LIM
CERE

Longfellow Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Longfellow Investment Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,723
Closed -$70.5K – 269
2024
Q2 		$70.5K Buy
1,723
+386
+29% +$16.1K 0.02% 153
2024
Q1 		$56.5K Buy
+1,337
New +$56.2K 0.01% 169

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Longfellow Investment Management's CERE Position: Q3 2024 in Review

Longfellow Investment Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 1,723 shares — an estimated $70.5K sold.

Longfellow Investment Management first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $70.5K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Longfellow Investment Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Longfellow Investment Management sold 1,723 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $70.5K.
  • Longfellow Investment Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Longfellow Investment Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $70.5K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Longfellow Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.